Esomeprazole IV + Omeprazole IV
Phase 3Completed 0 watching 0 views this week📈 Rising
77
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Gastrointestinal Hemorrhage
Conditions
Gastrointestinal Hemorrhage
Trial Timeline
Aug 1, 2006 → Oct 1, 2007
NCT ID
NCT00402259About Esomeprazole IV + Omeprazole IV
Esomeprazole IV + Omeprazole IV is a phase 3 stage product being developed by AstraZeneca for Gastrointestinal Hemorrhage. The current trial status is completed. This product is registered under clinical trial identifier NCT00402259. Target conditions include Gastrointestinal Hemorrhage.
Hype Score Breakdown
Clinical
27
Activity
18
Company
10
Novelty
9
Community
10
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00402259 | Phase 3 | Completed |
Competing Products
20 competing products in Gastrointestinal Hemorrhage